Shortage reports
Actual shortage:
250 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3299 (93%)
3563
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (12%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TICAGRELOR | 90MG | TABLET | Resolved | 2024-01-19 | 2024-03-29 | 216675 |
| APO-TICAGRELOR | 90MG | TABLET | Resolved | 2023-10-06 | 2023-12-08 | 206569 |
| APO-TICAGRELOR | 90MG | TABLET | Resolved | 2024-04-12 | 2024-07-05 | 225026 |
| APO-TICAGRELOR | 90MG | TABLET | Resolved | 2023-06-16 | 2023-08-23 | 195049 |
| APO-TICAGRELOR | 60MG | TABLET | Resolved | 2024-05-31 | 2024-07-19 | 229398 |
| APO-TICAGRELOR | 90MG | TABLET | Resolved | 2024-10-24 | 2025-01-10 | 241081 |
| APO-TIMOP | 0.5% | SOLUTION | Resolved | 2018-05-08 | 2019-02-05 | 48866 |
| APO-TIMOP | 0.5% | SOLUTION | Resolved | 2021-01-04 | 2021-12-13 | 130810 |
| APO-TIMOP | 0.5% | SOLUTION | Resolved | 2019-09-04 | 2020-07-29 | 92992 |
| APO-TIMOP | 0.5% | SOLUTION | Actual shortage | 2025-01-16 | 2025-12-11 | 247865 |
| APO-TIMOP | 0.5% | SOLUTION | Resolved | 2018-05-15 | 2018-11-02 | 49509 |
| APO-TIMOP | 0.5% | SOLUTION | Resolved | 2024-01-05 | 2024-06-28 | 215215 |
| APO-TIMOP GEL | 0.5% | SOLUTION | Resolved | 2017-03-11 | 2019-02-05 | 510 |
| APO-TIMOP OPH SOLN 0.25% | 0.25% | LIQUID | Resolved | 2017-03-11 | 2019-01-03 | 513 |
| APO-TIZANIDINE | 4MG | TABLET | Resolved | 2025-04-17 | 2025-06-17 | 255208 |
| APO-TOBRAMYCIN | 0.3% | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19123 |
| APO-TOLTERODINE | 2MG | TABLET | Resolved | 2017-03-11 | 2017-11-07 | 519 |
| APO-TOLTERODINE | 1MG | TABLET | Resolved | 2017-03-11 | 2017-11-08 | 516 |
| APO-TOLTERODINE | 2MG | TABLET | Resolved | 2017-03-11 | 2018-02-28 | 523 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2022-01-21 | 2022-02-18 | 153291 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |